Patient characteristics
| Characteristic . | All Patients (N = 154) . | R (n = 77) . | RL (n = 77) . | |||
|---|---|---|---|---|---|---|
| n . | % . | n . | % . | n . | % . | |
| Median (range) age, y | 62 (26-85) | 63 (29-85) | 61 (26-80) | |||
| ≥60 | 91 | 59 | 49 | 64 | 42 | 55 |
| ≥70 | 31 | 20 | 13 | 17 | 18 | 23 |
| Sex | ||||||
| Male | 72 | 47 | 37 | 48 | 35 | 45 |
| Female | 82 | 53 | 40 | 52 | 42 | 55 |
| Ann Arbor stage | ||||||
| II | 19 | 12 | 8 | 10 | 11 | 14 |
| III | 58 | 38 | 29 | 38 | 29 | 38 |
| IV | 77 | 50 | 40 | 52 | 37 | 48 |
| Performance status | ||||||
| 0 | 112 | 73 | 53 | 69 | 59 | 77 |
| 1 | 42 | 27 | 24 | 31 | 18 | 23 |
| B symptoms | ||||||
| Absent | 118 | 77 | 57 | 74 | 61 | 79 |
| Present | 36 | 23 | 20 | 26 | 16 | 21 |
| LDH* | ||||||
| Normal | 119 | 77 | 59 | 77 | 60 | 78 |
| Elevated | 32 | 21 | 17 | 22 | 15 | 19 |
| β2MG† | ||||||
| Normal | 83 | 54 | 40 | 52 | 43 | 56 |
| Elevated | 60 | 39 | 30 | 39 | 30 | 39 |
| Bulky disease, cm | ||||||
| <6 | 91 | 59 | 46 | 60 | 45 | 58 |
| ≥6 | 63 | 41 | 31 | 40 | 32 | 42 |
| Risk by FLIPI score | ||||||
| Low | 36 | 23 | 15 | 19 | 21 | 27 |
| Intermediate | 46 | 30 | 26 | 34 | 20 | 26 |
| High | 72 | 47 | 36 | 47 | 36 | 47 |
| Histologic grade | ||||||
| 1 | 38 | 25 | 18 | 23 | 20 | 26 |
| 2 | 91 | 59 | 46 | 60 | 45 | 58 |
| 3A | 25 | 16 | 13 | 17 | 12 | 16 |
| Characteristic . | All Patients (N = 154) . | R (n = 77) . | RL (n = 77) . | |||
|---|---|---|---|---|---|---|
| n . | % . | n . | % . | n . | % . | |
| Median (range) age, y | 62 (26-85) | 63 (29-85) | 61 (26-80) | |||
| ≥60 | 91 | 59 | 49 | 64 | 42 | 55 |
| ≥70 | 31 | 20 | 13 | 17 | 18 | 23 |
| Sex | ||||||
| Male | 72 | 47 | 37 | 48 | 35 | 45 |
| Female | 82 | 53 | 40 | 52 | 42 | 55 |
| Ann Arbor stage | ||||||
| II | 19 | 12 | 8 | 10 | 11 | 14 |
| III | 58 | 38 | 29 | 38 | 29 | 38 |
| IV | 77 | 50 | 40 | 52 | 37 | 48 |
| Performance status | ||||||
| 0 | 112 | 73 | 53 | 69 | 59 | 77 |
| 1 | 42 | 27 | 24 | 31 | 18 | 23 |
| B symptoms | ||||||
| Absent | 118 | 77 | 57 | 74 | 61 | 79 |
| Present | 36 | 23 | 20 | 26 | 16 | 21 |
| LDH* | ||||||
| Normal | 119 | 77 | 59 | 77 | 60 | 78 |
| Elevated | 32 | 21 | 17 | 22 | 15 | 19 |
| β2MG† | ||||||
| Normal | 83 | 54 | 40 | 52 | 43 | 56 |
| Elevated | 60 | 39 | 30 | 39 | 30 | 39 |
| Bulky disease, cm | ||||||
| <6 | 91 | 59 | 46 | 60 | 45 | 58 |
| ≥6 | 63 | 41 | 31 | 40 | 32 | 42 |
| Risk by FLIPI score | ||||||
| Low | 36 | 23 | 15 | 19 | 21 | 27 |
| Intermediate | 46 | 30 | 26 | 34 | 20 | 26 |
| High | 72 | 47 | 36 | 47 | 36 | 47 |
| Histologic grade | ||||||
| 1 | 38 | 25 | 18 | 23 | 20 | 26 |
| 2 | 91 | 59 | 46 | 60 | 45 | 58 |
| 3A | 25 | 16 | 13 | 17 | 12 | 16 |